Digest Network Come funziona
Network
/
Società
Mo
Non verificato

Motif Neurotech

Di cosa scriviamo

IndustriaMultimedialitàScienzaSoftwareVetrine/Shopping

3 comunicati stampa

Guarda tutti i comunicati
27/04/2026
Motif Neurotech Receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant Depression
Fonte
Motif Neurotech
Emittente
Business Wire
1.00
0
16/12/2025
Multimedialità
Industria
Scienza
Salute
Psichiatria
Motif Neurotech Launches Patient Registry for Future Research Opportunities
Fonte
Motif Neurotech
Emittente
Business Wire
1.00
0
20/01/2025
Motif Neurotech Wins UK Government Award to Develop Therapeutic Brain-Computer Interface
Fonte
Motif Neurotech
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0